Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AstraZeneca completes Iressa NDA for NSCLC

Aug. 8, 2002

Positive results for ursodiol in colorectal cancer

Aug. 8, 2002

Introgen to file European Advexin marketing application in 2004

Aug. 8, 2002

Atrix submits IND for new dosage form of Eligard

Aug. 8, 2002

Patient enrollment completed for phase III clinical trial with Tarceva

Aug. 7, 2002

Potential role for CEP-701 in the treatment of acute myeloid leukemia

Aug. 7, 2002

Novel topoisomerase I inhibitors in Advanced Life Sciences pipeline

Aug. 6, 2002

MTC-DOX designated orphan drug in E.U.

Aug. 6, 2002

Xyotax enters phase II trial in breast cancer

Aug. 6, 2002

Antitumor compound from natural source identified at Pharma Mar

Aug. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...